Table of Contents Table of Contents
Previous Page  219 / 490 Next Page
Information
Show Menu
Previous Page 219 / 490 Next Page
Page Background

217

POSTERS AND ELECTRONIC POSTERS

| PROGRAMME AND EXHIBITION GUIDE

ELECTRONIC POSTERS

> Advanced head & neck ca - chemoradiotherapy with conventional

fraction and accelerated fraction

H.A. Gaffor (India), F. Ruzina, C.H. Sridhar

EP-1081

> Interim 18F-FDG-PET/CT during chemoradiotherapy for early

outcome prediction of head and neck cancer

C. Garibaldi (Italy), S. Ronchi, M. Cremonesi, M. Ferrari, L. Gilardi,

L. Travaini, D. Ciardo, F. Botta, G. Baroni, C. Grana, B.A. Jereczek-Fossa,

R. Orecchia

EP-1082

> Usefulness of PET/CT in definition of treatment volumes of head and

neck tumors

L.P. Luigi Perrone (Italy), A.D. Anna Destito, R.M. Rosa Molè,

E.M. Elvira Mazzei, M.S. Mariaquila Santoro, M.A.M. Maria Angela

Molinaro, D.P. Domenicantonio Pingitore, C.B. Cataldo Bianco

EP-1083

> Elderly patients concomitant radiotherapy + cetuximab in locally

advanced head and neck cancer

A.T. Falk (France), C. Hébert, M. Paquet, A. Tran, F. Peyrade, E. Saada,

J. Reure, O. Dassonville, G. Poissonnet, A. Bozec, J. Thariat, A. Leysalle,

M.E. Chand, K. Benezery

EP-1084

> EGFR expression in head and neck cancer: does it have a role as

prognostic factor in radiotherapy?

D. Alterio, A. Ferrari, F. Maffini, G. Marvaso (Italy), L. Santoro, C. Fodor,

M. Cossu Rocca, M. Ansarin, S. Dicuonzo, M. Muto, D. Zerini, S. Chiocca,

R. Orecchia, B. Jereczek-Fossa

EP-1085

> Finding the right threshold for determining hypoxic subvolumes in

F-MISO-PET/CTs for HNSCC

H. Kerti, L. Majerus (Germany), A. Bunea, N. Wiedenmann, M. Mix,

C. Stoykow, P.T. Meyer, A.L. Grosu

EP-1086

> Screening for symptoms in HNC: Italian translation and validation of a

patient-reported outcome

M. Maddalo (Italy), M. Buglione, L. Costa, N. Pasinetti, S. Tonoli,

M. Urpis, L. Pegurri, S. Ciccarelli, F. Foscarini, F. Frassine, D. Tomasini,

S.M. Magrini

EP-1087

> Is time from symptom to treatment a prognostic factor in stage III-IV

head and neck cancer patients?

C. Furlan (Italy), J. Polesel, C. Gobitti, E. Minatel, E. Vaccher, L. Barzan,

G. Grando, G. Franchin

EP-1088